Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
VERA
#1670
Vera Therapeutics, Inc. Class A Common Stock
43.450
0
USD
-2.05%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-2.05%
Aylık Değişim
+7.10%
6 aylık değişim
+46.10%
Yıllık Değişim
+46.10%
Önceki Kapanış
44.360
0
Open
43.450
0
Bid
Ask
Low
43.450
0
High
43.450
0
Hacim
102
Piyasalar
ABD Borsası
Sağlık Hizmetleri
VERA
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
63.75 M
63.77 M
63.82 M
63.89 M
71.36 M
—
Valuation ratios
Enterprise value
2.66 B
1.53 B
1.53 B
1.88 B
3.35 B
8.29 B
Price to earnings ratio
-15.38
-8.01
-6.58
-7.28
-10.87
-32.74
Price to sales ratio
601.64
354.32
518.04
806.96
7 992.14
9 671.46
Price to cash flow ratio
-17.37
-8.94
-7.62
-8.57
-13.49
-38.61
Price to book ratio
4.05
0.8
0.75
0.9
5.5
7.94
Enterprise value to EBITDA ratio
-16.29
-8.09
-6.57
-7.01
-10.65
-32.32
Profitability ratios
Return on assets %
-0.07
-0.08
-0.13
-0.16
-0.12
-0.5
Return on equity %
-0.08
-0.1
-0.16
-0.2
-0.15
-0.61
Return on invested capital %
-2 450.51
—
—
—
-5 768.91
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-4 069.38
-6 462.6
23.78 K
-23.19 K
18.73 K
12.86 K
EBITDA margin %
-3 964.81
-6 352.99
23.85 K
-23.05 K
18.8 K
13.24 K
Net margin %
-3 612.73
-5 841.13
22.71 K
-22.18 K
18.11 K
12.8 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
25.67
27.68
17.03
12.21
13.64
70.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
-0
0
Solvency ratios
Debt to assets ratio
0.08
0.09
0.13
0.15
0.11
0.48
Debt to equity ratio
0.09
0.1
0.17
0.19
0.13
0.59
Long term debt to total assets ratio
0.08
0.08
0.13
0.14
0.1
0.46
Long term debt to total equity ratio
0.09
0.1
0.16
0.19
0.12
0.57
Per share metrics
Operating cash flow per share
-0.71
-0.85
-0.86
-0.97
-1.09
-3.77
EBIT per share
-0.86
-0.88
-1.26
-1.31
-1.47
-4.93
EBITDA per share
-0.86
-0.88
-1.26
-1.31
-1.47
-4.92
Total debt per share
0.99
0.86
1.22
1.21
1.2
4.48
Cash per share
11.58
9.26
8.73
7.79
11.12
36.91
Net current asset value per share
11.77
9.52
8.96
8.01
11.35
37.83
Tangible book value per share
10.43
8.4
7.34
6.25
9.21
31.2
Working capital per share
11.31
9.17
8.43
7.35
10.52
35.47
Book value per share
10.43
8.4
7.34
6.25
9.21
31.2
Haberler
Vera Therapeutics, Jane Wright-Mitchell’ı hukuk müdürü atadı
Wolfe Research, Vera Therapeutics hissesini değerleme üzerinden yükseltti
Wolfe Research upgrades Vera Therapeutics stock rating on valuation
BofA Securities, Vera Therapeutics için Al tavsiyesini yineledi
Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities
Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Vera Therapeutics adds Christopher Hite to board of directors
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com
Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg
Vera Therapeutics, Matt Skelton’u ticari operasyonlar direktörü olarak terfi ettirdi
Vera Therapeutics promotes Matt Skelton to chief commercial officer